S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
3 Words and a 3,000% Return (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
3 Words and a 3,000% Return (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
3 Words and a 3,000% Return (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
3 Words and a 3,000% Return (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
3 Words and a 3,000% Return (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
3 Words and a 3,000% Return (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
3 Words and a 3,000% Return (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
3 Words and a 3,000% Return (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Ukraine targets a key Crimean city a day after striking Russia's Black Sea Fleet headquarters
NASDAQ:RSLS

ReShape Lifesciences (RSLS) News Today

$0.59
-0.02 (-3.28%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.58
$0.66
50-Day Range
$0.59
$1.53
52-Week Range
$0.57
$22.40
Volume
30,132 shs
Average Volume
81,810 shs
Market Capitalization
$2.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
SourceHeadline
finance.yahoo.com logoReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
finance.yahoo.com - September 22 at 9:59 AM
finance.yahoo.com logoReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System
finance.yahoo.com - September 19 at 9:55 AM
finanznachrichten.de logoReShape Lifesciences Inc: ReShape Lifesciences Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Device
finanznachrichten.de - September 14 at 1:04 PM
finance.yahoo.com logoReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device
finance.yahoo.com - September 14 at 1:04 PM
uk.finance.yahoo.com logoRSLS - ReShape Lifesciences Inc.
uk.finance.yahoo.com - September 13 at 5:01 PM
insidermonkey.com logoReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript
insidermonkey.com - August 9 at 5:15 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Augmedix (AUGX), ReShape Lifesciences (RSLS)
markets.businessinsider.com - August 9 at 8:03 AM
finance.yahoo.com logoQ2 2023 ReShape Lifesciences Inc Earnings Call
finance.yahoo.com - August 8 at 9:57 AM
finance.yahoo.com logoReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 9:57 AM
finance.yahoo.com logoReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update
finance.yahoo.com - August 3 at 5:57 PM
finanznachrichten.de logoReShape Lifesciences Inc: ReShape Lifesciences Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software
finanznachrichten.de - June 29 at 10:00 AM
finance.yahoo.com logoReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software
finance.yahoo.com - June 29 at 10:00 AM
finance.yahoo.com logoReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
finance.yahoo.com - June 28 at 9:14 AM
finanznachrichten.de logoReShape Lifesciences Inc: ReShape Lifesciences Submits FDA PMA Supplement Application for the Next-Generation Lap-Band 2.0
finanznachrichten.de - June 27 at 7:41 AM
finance.yahoo.com logoReShape Lifesciences® to Participate in Investor and Industry Conferences in June
finance.yahoo.com - June 14 at 9:19 AM
finance.yahoo.com logoQ1 2023 ReShape Lifesciences Inc Earnings Call
finance.yahoo.com - May 16 at 8:20 AM
finance.yahoo.com logoReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - May 15 at 5:18 PM
finance.yahoo.com logoReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Update
finance.yahoo.com - May 11 at 12:34 PM
marketwatch.com logoReShape Lifesciences(R) to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device at the Keystone Symposia on Type 2 Diabetes
marketwatch.com - April 28 at 1:23 AM
finance.yahoo.com logoReShape Lifesciences® Reports Year Ended December 31, 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - April 25 at 8:43 PM
markets.businessinsider.com logoReShape Lifesciences (RSLS) Gets a Buy from Maxim Group
markets.businessinsider.com - April 25 at 3:42 PM
finance.yahoo.com logoInvestors Continue Waiting On Sidelines For ReShape Lifesciences Inc. (NASDAQ:RSLS)
finance.yahoo.com - April 19 at 3:58 PM
seekingalpha.com logoReShape Lifesciences gets patent for Obalon balloon system
seekingalpha.com - April 11 at 1:40 PM
benzinga.com logoReshape Lifesciences Stock (NASDAQ:RSLS), Guidance and Forecast
benzinga.com - March 30 at 3:20 PM
finance.yahoo.com logoReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Call
finance.yahoo.com - March 29 at 1:00 AM
finance.yahoo.com logoReShape Lifesciences Announces Formation of International Scientific Advisory Board
finance.yahoo.com - March 23 at 9:05 AM
finance.yahoo.com logoReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update
finance.yahoo.com - March 22 at 9:01 AM
marketwatch.com logoReShape Lifesciences(R) to Present at the Q2 Virtual Investor Summit
marketwatch.com - March 17 at 11:28 PM
finance.yahoo.com logoReShape Lifesciences® to Present at the Q2 Virtual Investor Summit
finance.yahoo.com - March 15 at 8:39 AM
marketbeat.com logo
marketbeat.com - February 8 at 12:25 PM
marketwatch.com logoReShape Lifesciences Shares Drop 60% After Public Offering Prices
marketwatch.com - February 6 at 11:09 AM
msn.com logoWhy ReShape Lifesciences (RSLS) Shares Are Plummeting
msn.com - February 6 at 11:09 AM
finance.yahoo.com logoReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering
finance.yahoo.com - February 6 at 11:09 AM
finance.yahoo.com logoReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering
finance.yahoo.com - February 6 at 11:09 AM
marketwatch.com logoReShape Lifesciences Stock More Than Doubles to $14.39
marketwatch.com - February 4 at 12:15 AM
marketbeat.com logo
marketbeat.com - February 3 at 10:24 AM
marketbeat.com logo
marketbeat.com - February 3 at 10:14 AM
marketbeat.com logo
marketbeat.com - February 3 at 9:58 AM
marketbeat.com logo
marketbeat.com - February 3 at 9:52 AM
marketbeat.com logo
marketbeat.com - February 3 at 9:46 AM
marketbeat.com logo
marketbeat.com - February 3 at 9:39 AM
marketbeat.com logo
marketbeat.com - February 3 at 9:35 AM
msn.com logoLooking Into Reshape Lifesciences's Recent Short Interest
msn.com - January 4 at 2:15 PM
marketbeat.com logo
marketbeat.com - January 3 at 1:20 PM
marketbeat.com logo
marketbeat.com - January 3 at 10:17 AM
marketbeat.com logo
marketbeat.com - January 3 at 10:10 AM
marketbeat.com logo
marketbeat.com - January 3 at 10:05 AM
marketbeat.com logo
marketbeat.com - January 3 at 9:45 AM
marketbeat.com logo
marketbeat.com - January 3 at 9:35 AM
marketbeat.com logo
marketbeat.com - December 29 at 11:07 AM
Get ReShape Lifesciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter.



RSLS Media Mentions By Week

RSLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RSLS
News Sentiment

0.61

0.51

Average
Medical
News Sentiment

RSLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RSLS Articles
This Week

2

1

RSLS Articles
Average Week

Get ReShape Lifesciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:RSLS) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -